Agenda

8:00 am – 8:30 am Registration and Breakfast
8:30 am – 8:40 am Introduction and Pretest
8:40 am – 9:05 am Advances in the Immunopathogenesis of Rheumatic Diseases: Lessons from Checkpoint Immunotherapy of Cancer
9:05 am – 9:30 am Treatment Guidelines for RA 2017: Implementation and Controversies for Efficacy and Safety
9:30 am – 9:40 am Clinical Case I: Panel Discussion
9:40 am – 9:50 am Posttest and Question and Answer
9:50 am – 10:05 am Break
10:05 am – 10:25 am Clinical Advances in RA: Emerging Therapies
10:25 am – 10:45 am Clinical Cases II and III: Panel Discussion
10:45 am – 11:05 am Biosimilars in the Clinic: Motivators and Barriers
11:05 am – 11:15 am Posttest and Question and Answer
11:15 am Meeting Adjournment

Slide to view agenda